BioLineRx logo

BioLineRx

BLRX | NASDAQ
Chart Builder DCF Calculator
$1.19
-$0.11 (-8.46%)
At close: Nov 16, 2026, 3:59 PM ET
$1.16
-$0.03 (-2.39%)
After-hours: Nov 16, 2026, 7:30 PM ET
-8.46%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
36.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #619/1021 (Top 61%)

Key Statistics

Market Data

Market Cap $5.92M
1D Range
1.14 1.33
52W Range
1.14 3.78

Valuation (TTM)

PE -0.66
PB 0.43
EV/EBITDA -0.10

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Loading financial charts...

Profile

BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. Their leading investigational pr...

Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Jul 27, 2011
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 23, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.